AP NEWS

Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Outlook (2019-2023): Increasing Second- and Third-Line Therapies - ResearchAndMarkets.com

December 4, 2018

DUBLIN--(BUSINESS WIRE)--Dec 4, 2018--The “Global Idiopathic Thrombocytopenic Purpura Therapeutics Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.

The Global Idiopathic Thrombocytopenic Purpura Therapeutics Market is projected to grow at a CAGR of 5.41% during the period 2019-2023.One trend affecting this market is the development of combination therapy for ITP. The ITP market is coming up with many combination therapies for the treatment of the disease with many positive outcomes. According to the report, one driver influencing this market is the increasing second- and third-line therapies. The global ITP therapeutics market is witnessing an increase in the inflow of second and third-line therapies to meet the unmet needs of ITP. Further, the report states that one challenge affecting this market is the side effects of approved treatment. Many approved therapeutics cause serious side effects which is a key challenge in the global ITP therapeutics market.

Key Vendors

AmgenBristol-Myers SquibbEisaiMerck Sharp & DohmeNovartis

Topics Covered

1. Executive Summary

2. Scope of the Report

3. Market Landscape

4. Market Sizing

5. Five Forces Analysis

6. Market Segmentation by Product

7. Customer Landscape

8. Geographic Landscape

9. Decision Framework

10. Drivers and Challenges

11. Market Trends

12. Vendor Landscape

13. Vendor Analysis

For more information about this report visit https://www.researchandmarkets.com/research/g4q6xp/global_idiopathic?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181204005465/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Hematological Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/04/2018 04:54 AM/DISC: 12/04/2018 04:54 AM

http://www.businesswire.com/news/home/20181204005465/en

AP RADIO
Update hourly